Umbilical cord tissue is the most powerful source of mesenchymal stem cells available. APEX supplies ethically sourced UC-MSCs from Wharton's Jelly — collected from consenting donors after healthy, full-term births and processed in FDA-registered facilities.
Umbilical cord tissue — specifically Wharton's Jelly — contains the youngest, most potent mesenchymal stem cells available. Unlike bone marrow or adipose-derived cells which decline in quality with age, cord tissue MSCs are collected at the very beginning of life, when regenerative potential is at its peak.
APEX sources all stem cells from umbilical cord tissue donated by healthy mothers after full-term cesarean births. Every donor undergoes rigorous screening, and all tissues are processed in FDA-registered, ISO-certified facilities following AATB and AABB guidelines. No harm comes to the mother or newborn — the tissue would otherwise be discarded as medical waste.
The science behind why cord-derived MSCs outperform other stem cell sources.
Collected at birth, UC-MSCs have the highest proliferative capacity and telomere length of any MSC source. Younger cells mean more divisions, more growth factors, and stronger regenerative signaling.
Umbilical cord MSCs express fewer HLA markers than adult-derived cells, reducing the risk of immune response and making them suitable for allogeneic (donor-to-patient) applications.
UC-MSCs produce higher concentrations of exosomes, cytokines, and growth factors compared to bone marrow or fat-derived MSCs — amplifying their regenerative effect through cell-to-cell signaling.
Complete transparency from sourcing to treatment.
Umbilical cord tissue donated by consenting mothers after healthy, full-term cesarean births. Rigorous donor screening and documentation.
Tissue processed in FDA-registered, ISO-certified facilities following current Good Manufacturing Practices with full quality control.
Product shipped via monitored cold-chain logistics directly to your practice with complete documentation and chain-of-custody records.
Administered by your trained team using APEX protocols — either via IV infusion or targeted injection with BioScaf scaffolding.
Our stem cells are derived from umbilical cord Wharton's Jelly, donated with full consent by healthy mothers after full-term cesarean births. The tissue would otherwise be discarded as medical waste.
Absolutely. Collection occurs after a healthy delivery and poses no risk to the mother or newborn. All donors undergo rigorous screening, and consent is obtained in advance. The process follows established ethical guidelines for human tissue donation.
Every lot undergoes infectious disease testing (HIV, Hepatitis B/C, Syphilis, and more), sterility testing, endotoxin testing, and viability assessment. Full certificates of analysis are provided with each order.
Cord blood banking stores a baby's own cord blood for potential future use. APEX provides commercially processed allogeneic umbilical cord tissue-derived stem cells for clinical use by medical professionals — these are two very different products and markets.
Yes. APEX offers umbilical cord stem cells in both IV and injection configurations, allowing you to serve patients seeking systemic wellness treatments and targeted regenerative therapy.
Ethically sourced. Rigorously tested. Fully documented. APEX supplies the highest quality umbilical cord MSCs with the training and support to build a profitable program.